Cargando…

Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine

Understanding the heterogeneity of groups along the vaccine hesitancy continuum presents an opportunity to tailor and increase the impact of public engagement efforts with these groups. Audience segmentation can support these goals, as demonstrated here in the context of the 2009 H1N1 vaccine. In Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanadhan, Shoba, Galarce, Ezequiel, Xuan, Ziming, Alexander-Molloy, Jaclyn, Viswanath, Kasisomayajula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586467/
https://www.ncbi.nlm.nih.gov/pubmed/26350595
http://dx.doi.org/10.3390/vaccines3030556
_version_ 1782392364169428992
author Ramanadhan, Shoba
Galarce, Ezequiel
Xuan, Ziming
Alexander-Molloy, Jaclyn
Viswanath, Kasisomayajula
author_facet Ramanadhan, Shoba
Galarce, Ezequiel
Xuan, Ziming
Alexander-Molloy, Jaclyn
Viswanath, Kasisomayajula
author_sort Ramanadhan, Shoba
collection PubMed
description Understanding the heterogeneity of groups along the vaccine hesitancy continuum presents an opportunity to tailor and increase the impact of public engagement efforts with these groups. Audience segmentation can support these goals, as demonstrated here in the context of the 2009 H1N1 vaccine. In March 2010, we surveyed 1569 respondents, drawn from a nationally representative sample of American adults, with oversampling of racial/ethnic minorities and persons living below the United States Federal Poverty Level. Guided by the Structural Influence Model, we assessed knowledge, attitudes, and behaviors related to H1N1; communication outcomes; and social determinants. Among those who did not receive the vaccine (n = 1166), cluster analysis identified three vaccine-hesitant subgroups. Disengaged Skeptics (67%) were furthest from vaccine acceptance, with low levels of concern and engagement. The Informed Unconvinced (19%) were sophisticated consumers of media and health information who may not have been reached with information to motivate vaccination. The Open to Persuasion cluster (14%) had the highest levels of concern and motivation and may have required engagement about vaccination broadly. There were significant sociodemographic differences between groups. This analysis highlights the potential to use segmentation techniques to identify subgroups on the vaccine hesitancy continuum and tailor public engagement efforts accordingly.
format Online
Article
Text
id pubmed-4586467
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-45864672015-10-06 Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine Ramanadhan, Shoba Galarce, Ezequiel Xuan, Ziming Alexander-Molloy, Jaclyn Viswanath, Kasisomayajula Vaccines (Basel) Article Understanding the heterogeneity of groups along the vaccine hesitancy continuum presents an opportunity to tailor and increase the impact of public engagement efforts with these groups. Audience segmentation can support these goals, as demonstrated here in the context of the 2009 H1N1 vaccine. In March 2010, we surveyed 1569 respondents, drawn from a nationally representative sample of American adults, with oversampling of racial/ethnic minorities and persons living below the United States Federal Poverty Level. Guided by the Structural Influence Model, we assessed knowledge, attitudes, and behaviors related to H1N1; communication outcomes; and social determinants. Among those who did not receive the vaccine (n = 1166), cluster analysis identified three vaccine-hesitant subgroups. Disengaged Skeptics (67%) were furthest from vaccine acceptance, with low levels of concern and engagement. The Informed Unconvinced (19%) were sophisticated consumers of media and health information who may not have been reached with information to motivate vaccination. The Open to Persuasion cluster (14%) had the highest levels of concern and motivation and may have required engagement about vaccination broadly. There were significant sociodemographic differences between groups. This analysis highlights the potential to use segmentation techniques to identify subgroups on the vaccine hesitancy continuum and tailor public engagement efforts accordingly. MDPI 2015-07-15 /pmc/articles/PMC4586467/ /pubmed/26350595 http://dx.doi.org/10.3390/vaccines3030556 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ramanadhan, Shoba
Galarce, Ezequiel
Xuan, Ziming
Alexander-Molloy, Jaclyn
Viswanath, Kasisomayajula
Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine
title Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine
title_full Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine
title_fullStr Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine
title_full_unstemmed Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine
title_short Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine
title_sort addressing the vaccine hesitancy continuum: an audience segmentation analysis of american adults who did not receive the 2009 h1n1 vaccine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586467/
https://www.ncbi.nlm.nih.gov/pubmed/26350595
http://dx.doi.org/10.3390/vaccines3030556
work_keys_str_mv AT ramanadhanshoba addressingthevaccinehesitancycontinuumanaudiencesegmentationanalysisofamericanadultswhodidnotreceivethe2009h1n1vaccine
AT galarceezequiel addressingthevaccinehesitancycontinuumanaudiencesegmentationanalysisofamericanadultswhodidnotreceivethe2009h1n1vaccine
AT xuanziming addressingthevaccinehesitancycontinuumanaudiencesegmentationanalysisofamericanadultswhodidnotreceivethe2009h1n1vaccine
AT alexandermolloyjaclyn addressingthevaccinehesitancycontinuumanaudiencesegmentationanalysisofamericanadultswhodidnotreceivethe2009h1n1vaccine
AT viswanathkasisomayajula addressingthevaccinehesitancycontinuumanaudiencesegmentationanalysisofamericanadultswhodidnotreceivethe2009h1n1vaccine